Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

HYDROZONES · Bioactivated hierarchical hydrogels as zonal implants for articular cartilage regeneration

FP7Status: CLOSED1 January 201331 December 2017EU funding €9,749,700

Degeneration of cartilage is a major cause of chronic pain, lost mobility and reduced quality of life for millions of European citizens. From a clinical point of view treatment to achieve cartilage regeneration (hyaline) and not only repair (fibrous) remains a great challenge. No clinical therapy is available that leads to healing of cartilage defects.Current cartilage implants cannot establish the hierarchical tissue organisation that appears critical for normal cartilage function. We hypothesise that a biomimetic zonal organisation is critical for implants to achieve cartilage regeneration.HydroZONES represents an interdisciplinary consortium that adopts a strategy to regenerate, rather than repair, articular cartilage based on the tissues zonal structure and function.HydroZONES will use advanced bioprinting technology for fabrication of 3D biofunctional hydrogel constructs, eventually mechanically reinforced by degradable polymer scaffolds, as biomimetic reconstitution of the zonal organisation of natural cartilage. Constructs will be optimized for cell-free application and also for combination with chrondrogenic cells (chondrocytes and/or MSC). Stringent in vitro and long term in vivo testing of the constructs will be employed that will yield a new clinical standard for pre-clinical testing.Cutting edge 3D tissue models and bioreactor technology will be used together with in silico modelling to develop a predictive in vitro assay and test system that will be validated against the in vivo data.Installation of a quality and regulatory affair management system, GMP production, accredited in vitro testing and involvement of clinical partners and companies with experience in clinical trials ensures that the best performing construct will be brought into an optimal position for entering clinical trials at project end. HydroZONES will thus advance the European Union as world leader in the field of joint cartilage regeneration.

Consortium · 17 organisations

coordinator

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT

DE · €2,609,470

participant

ARTTIC

FR · €171,884

participant

QUEENSLAND UNIVERSITY OF TECHNOLOGY - QLD QUT

AU

participant

INSTITUTO POLITECNICO DE LEIRIA

PT · €200,945

participant

CELLCOTEC BV

NL · €300,000

participant

LIFETEC GROUP BV

NL · €479,040

participant

STICHTING PROTOSPACE

NL · €117,166

participant

POLYVATION BV

NL · €498,851

participant

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €834,358

participant

UNIVERSIDAD DE NAVARRA

ES · €818,166

participant

GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG

DE · €146,521

participant

MICHAEL HUBERT BARFUSS

DE · €298,176

participant

UNIVERSITATSKLINIKUM HEIDELBERG

DE · €858,097

participant

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

UK · €458,254

participant

UNIVERSITEIT UTRECHT

NL · €1,272,998

participant

JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG

DE · €134,762

participant

LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV

DE · €551,012

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.